Skip to main content

Advertisement

SpringerLink
Log in

The cancer‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Osteosarcoma is the most common primary bone cancer in children and young adults. Recent experimental evidence has indicated that Runx2/OPN axis play important roles in the metastasis of osteosarcoma cells. The present study aimed to explore their relationship and prognostic significance in surgically resected osteosarcoma.

Methods

The expression of runt‐related transcription factor2(Runx2) and osteopontin (OPN) in clinical specimens from 105 osteosarcoma patients were detected by immunohistochemistry. The correlations between Runx2, OPN, and clinicopathologic data were analyzed by Chi-square (χ2) tests. The prognostic values were determined by univariate and multivariate survival analysis. The accuracy of oncologic outcome prediction was evaluated by receiver-operating characteristics curves.

Results

The results showed there is a significant positive correlation between Runx2 and OPN expression at protein levels (P = 0.015). Runx2 and OPN were both independent predictors for overall survival and metastasis-free survival. When Runx2 and OPN were taken into consideration together, the predictive range was extended and the sensitivity was improved, and more significant and better biomarkers for osteosarcoma metastasis and survival.

Conclusions

These results suggest that a combined Runx2/OPN expression could be a valuable independent predictor of tumor metastasis and survival in osteosarcoma patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig.1
Fig. 2

Similar content being viewed by others

Data availability

The data used in this study are available from the corresponding author on reasonable request.

References

  1. Ritter J, Bielack SS (2010) Osteosarcoma. Ann Oncol 21(7):vii320-325. https://doi.org/10.1093/annonc/mdq276

    Article  PubMed  Google Scholar 

  2. Maugg D, Rothenaigner I, Schorpp K et al (2015) New small molecules targeting apoptosis and cell viability in osteosarcoma. PLoS One 10(6):e0129058. https://doi.org/10.1371/journal.pone.0129058

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ferguson WS, Goorin AM (2001) Current treatment of osteosarcoma. Cancer Invest 19(3):292–315. https://doi.org/10.1081/cnv-100102557

    Article  CAS  PubMed  Google Scholar 

  4. Ducy P, Zhang R, Geoffroy V et al (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89(5):747–754. https://doi.org/10.1016/s0092-8674(00)80257-3

    Article  CAS  PubMed  Google Scholar 

  5. Villanueva F, Araya H, Briceño P et al (2019) The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis. J Cell Physiol 234(8):13659–13679. https://doi.org/10.1002/jcp.28046

    Article  CAS  PubMed  Google Scholar 

  6. Wai PY, Mi Z, Gao C et al (2006) Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. J Biol Chem 281(28):18973–18982. https://doi.org/10.1074/jbc.M511962200

    Article  CAS  PubMed  Google Scholar 

  7. Onodera Y, Miki Y, Suzuki T et al (2010) Runx2 in human breast carcinoma: its potential roles in cancer progression. Cancer Sci 101(12):2670–2675. https://doi.org/10.1111/j.1349-7006.2010.01742.x

    Article  CAS  PubMed  Google Scholar 

  8. Sase T, Suzuki T, Miura K et al (2012) Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor. Int J Cancer 131(10):2284–2293. https://doi.org/10.1002/ijc.27525

    Article  CAS  PubMed  Google Scholar 

  9. Yang J, Zhao L, Tian W et al (2013) Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma. BMC Med Genomics 6:56. https://doi.org/10.1186/1755-8794-6-56

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Gupta S, Ito T, Alex D et al (2019) RUNX2 (6p21.1) amplification in osteosarcoma. Hum Pathol 94:23–28. https://doi.org/10.1016/j.humpath.2019.09.010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lucero CM, Vega OA, Osorio MM et al (2013) The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines. J Cell Physiol 228(4):714–723. https://doi.org/10.1002/jcp.24218

    Article  CAS  PubMed  Google Scholar 

  12. Wei R, Wong JPC, Kwok HF (2017) Osteopontin–a promising biomarker for cancer therapy. J Cancer 8(12):2173–2183. https://doi.org/10.7150/jca.20480

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Han X, Wang W, He J et al (2019) Osteopontin as a biomarker for osteosarcoma therapy and prognosis. Oncol Lett 17(3):2592–2598. https://doi.org/10.3892/ol.2019.9905

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Liu SJ, Hu GF, Liu YJ et al (2004) Effect of human osteopontin on proliferation, transmigration and expression of MMP-2 and MMP-9 in osteosarcoma cells. Chin Med J (Engl) 117(2):235–240

    CAS  Google Scholar 

  15. Meyers PA, Heller G, Healey J et al (1992) Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 10(1):5–15. https://doi.org/10.1200/jco.1992.10.1.5

    Article  CAS  PubMed  Google Scholar 

  16. Bacci G, Bertoni F, Longhi A et al (2003) Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 97(12):3068–3075. https://doi.org/10.1002/cncr.11456

    Article  CAS  PubMed  Google Scholar 

  17. Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106–120

    Article  Google Scholar 

  18. Ren Z, Liang S, Yang J et al (2016) Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma. Tumour Biol 37(4):5089–5096. https://doi.org/10.1007/s13277-015-4352-8

    Article  CAS  PubMed  Google Scholar 

  19. Stein GS, Lian JB, van Wijnen AJ et al (2004) Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23(24):4315–4329. https://doi.org/10.1038/sj.onc.1207676

    Article  CAS  PubMed  Google Scholar 

  20. Lengner CJ, Steinman HA, Gagnon J et al (2006) Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J Cell Biol 172(6):909–921. https://doi.org/10.1083/jcb.200508130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Martin JW, Zielenska M, Stein GS et al (2011) The role of RUNX2 in osteosarcoma oncogenesis. Sarcoma 2011:282745. https://doi.org/10.1155/2011/282745

    Article  CAS  PubMed  Google Scholar 

  22. Sadikovic B, Yoshimoto M, Chilton-MacNeill S et al (2009) Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling. Hum Mol Genet 18(11):1962–1975. https://doi.org/10.1093/hmg/ddp117

    Article  CAS  PubMed  Google Scholar 

  23. Won KY, Park HR, Park YK (2009) Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma. Tumori 95(3):311–316

    Article  CAS  Google Scholar 

  24. Senger DR, Wirth DF, Hynes RO (1979) Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell 16(4):885–893. https://doi.org/10.1016/0092-8674(79)90103-x

    Article  CAS  PubMed  Google Scholar 

  25. Luo X, Chen J, Song WX et al (2008) Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest 88(12):1264–1277. https://doi.org/10.1038/labinvest.2008.98

    Article  CAS  PubMed  Google Scholar 

  26. Velupillai P, Sung CK, Tian Y et al (2010) Polyoma virus-induced osteosarcomas in inbred strains of mice: host determinants of metastasis. PLoS Pathog 6(1):e1000733. https://doi.org/10.1371/journal.ppat.1000733

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No funding was received.

Author information

Authors and Affiliations

  1. Department of Bone Disease, The Second Hospital of Tangshan, No.21, Jianshe North Road, Tangshan, 063000, China

    Shoulei Liang, Yong Li & Baocang Wang

Authors
  1. Shoulei Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Baocang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Baocang Wang.

Ethics declarations

Conflict of interest

None of the authors have any conflicts of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 15 KB)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liang, S., Li, Y. & Wang, B. The cancer‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma. Int J Clin Oncol 26, 2347–2354 (2021). https://doi.org/10.1007/s10147-021-02025-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-021-02025-4

Keywords

Search

Navigation